Previous close | 10.19 |
Open | 8.10 |
Bid | 8.90 x 400 |
Ask | 8.96 x 500 |
Day's range | 7.81 - 8.96 |
52-week range | 6.88 - 13.77 |
Volume | |
Avg. volume | 128,509 |
Market cap | 283.753M |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | 38.83 |
EPS (TTM) | 0.23 |
Earnings date | 24 Oct 2024 - 28 Oct 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | 05 Jan 2022 |
1y target est | 19.88 |
Zynex (ZYXI) delivered earnings and revenue surprises of -50% and 3.70%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today reported its financial and operational results for the second quarter ended June 30, 2024.